BioCentury
ARTICLE | Finance

Mitsubishi the matchmaker

Mitsubishi UFJ Capital plans to facilitate biotech, pharma deals with new fund

March 30, 2017 11:02 PM UTC

With a second dedicated life sciences fund, Mitsubishi UFJ Capital Co. Ltd. plans to promote partnerships and licensing deals between its portfolio companies and Japanese pharmas served by its parent company Mitsubishi UFJ Financial Group Inc.

Mitsubishi UFJ Life Science I L.P. closed on March 20 at ¥10 billion ($89 million). ...

BCIQ Company Profiles

Mitsubishi UFJ Capital Co. Ltd.